Device Trial Radar · NCT01268345
AST Clinical Investigation
Last checked: Nov 20, 2026Latest source record: Dec 30, 2010 (this record)Source: ClinicalTrials.govMethods & limitations
Sponsor
- Lead sponsor
- Andon Medical Co.,LtdNot on our public-company list
- Sponsor type
- Industry
- First posted
- Dec 30, 2010
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Diagnostic
- Who can join
- All sexes, from 21 years, up to 78 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Blood glucose monitoring system are tested in the alternative site to validate the accuracy of the blood glucose.
Conditions
- Diabetes
Interventions
blood glucose monitorDevice
Blood glucose monitor is used to monitor the blood glucose level of the human-being
blood glucose monitorDevice
Blood glucose monitor is used to monitor the blood glucose level of the human-being.
Primary outcomes
What the sponsor says the trial is designed to measure.
- blood glucose valueTime frame: 5 seconds
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Tianjin Hexi Ruijing metabolism hospital
Tianjin, Tianjin Municipality, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.